← All trials
NCT04657107
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2020
- Primary completion
- Dec 15, 2021
- Completion date
- Jul 1, 2022
- First posted
- Dec 8, 2020
- Last posted
- Dec 8, 2020
- Enrollment
- 402
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Capital Medical UniversityLead sponsor
- Fudan UniversityCollaborator
- Fudan UniversityOverall official - principal investigator
- Capital Medical UniversityReponsible party - principal investigator
- Beijing Chaoyang District Maternal and Child Health Care HospitalOverall official - principal investigator
- Beijing Chaoyang District Maternal and Child Health Care HospitalCollaborator
- Haidian Maternal and Child Health HospitalOverall official - principal investigator
- Haidian Maternal and Child Health HospitalCollaborator
- Changzhi Maternal and Child Health HospitalOverall official - principal investigator
- Changzhi Maternal and Child Health HospitalCollaborator
- China Health Promotion FoundationCollaborator
- Fourth Hospital of Shijiazhuang CityOverall official - principal investigator
- Fourth Hospital of Shijiazhuang CityCollaborator
- Linfen Maternity&Child Healthcare HospitalOverall official - principal investigator
- Linfen Maternity&Child Healthcare HospitalCollaborator
- Maternal and Child Health Hospital, Jiading DistrictOverall official - principal investigator
- Maternal and Child Health Hospital, Jiading DistrictCollaborator
- Tongzhou Maternal and Child Healthcare Hospital of BeijingOverall official - principal investigator
- Tongzhou Maternal and Child Healthcare Hospital of BeijingCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.